LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC
Alexandria TM Lee,1 Sai-Hong Ignatius Ou2 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, 92868, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, 92868, USACorrespondence: Sai-Hong Ignatius Ou, Department of Medicine, Division of Hematology-Oncology...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2024-05-01
|
| Colección: | Lung Cancer: Targets and Therapy |
| Materias: | |
| Acceso en línea: | https://www.dovepress.com/libretto-431-confirming-the-superiority-of-selpercatinib-to-chemothera-peer-reviewed-fulltext-article-LCTT |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|